How stress responses in immune cells affect infections from Salmonella bacteria

Integrated Stress Response-mediated macrophage innate immunity during maladapted Salmonella enterica infection

['FUNDING_FELLOWSHIP'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-10994355

This study is looking at how stress affects certain immune cells in our body that help fight off infections like typhoid fever, with the hope of finding new ways to boost our immune response against these types of bacteria.

Quick facts

Phase['FUNDING_FELLOWSHIP']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded)
Locations1 site (ANN ARBOR, UNITED STATES)
Trial IDNIH-10994355 on ClinicalTrials.gov

What this research studies

This research investigates how stress responses in immune cells, specifically macrophages, influence the body's ability to fight off infections caused by Salmonella enterica, the bacteria responsible for typhoid fever. By studying how these immune cells adapt to stress during infection, the research aims to uncover mechanisms that could lead to new treatments. The approach involves using a model of infection to observe how the Integrated Stress Response (ISR) pathway is activated and how it affects immune function. The findings could provide insights into how to enhance immune responses against this global health threat.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who are at risk of or have been diagnosed with typhoid fever or related Salmonella infections.

Not a fit: Patients who do not have a history of Salmonella infections or are not at risk for typhoid fever may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of targeted therapies that improve immune responses to Salmonella infections, potentially reducing the incidence and severity of typhoid fever.

How similar studies have performed: Previous research has shown that understanding stress responses in immune cells can lead to significant advancements in treating infectious diseases, suggesting that this approach has potential for success.

Where this research is happening

ANN ARBOR, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.